BACK TO ALL REFERENCES
UNLOOC: Mitigating the use of animal testing in drug development
UNLOOC mitigates the use of animal testing in drug development and shows how European health innovation can improve diagnosis, treatment and patient care.
€68 m
in funding
3
years
51
partners
10
countries
Key numbers
About the project
UNLOOC seeks to improve drug testing methods using human cell models to circumvent these issues related to animal drug testing. UNLOOC intends to demonstrate through its five use cases how OOC technology can create more effective treatments, leaving animal subjects out of the equation. The OOC systems will also model disease pathophysiology, offering a more controlled approach to drug testing. OOC technology replicates human organ functions on a miniature scale, using microfluidic channels and living cells, thus providing a potent tool for drug development and disease research.
Impact of the project:
Mitigating the use of animals in drug development and tackling gender disparities in clinical research.
Funding instrument Chips JU
Spinverse’s role
Spinverse’s health domain experts initially supported UNLOOC with project planning, consortium building and project proposal writing for the competitive KDT funding call (currently known as Chips JU).
Spinverse continuesd to support the consortium with daily administration and communication services.
It was a pleasure working closely with Juho in the preparation of the proposal and it was amazing how the Spinverse team delivered on point. Now, being in the project phase with a multitude of technical and admin activities running in parallel, I am grateful to have Malin as seasoned project manager at my side. I can only say Thank you!
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
